Authors/Disclosures
|
Elinor Ben-Menachem, MD, FAAN
(Dept of Clinical Neuroscience)
|
Dr. Ben-Menachem has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Ben-Menachem has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arvelle. Dr. Ben-Menachem has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for GW Pharma. Dr. Ben-Menachem has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Acta Neurologica Scandinvica. The institution of Dr. Ben-Menachem has received research support from zogenic. |
|
Bashair Ibrahim
(King Abdulaziz University)
|
No disclosure on file |
|
Martin Brodie
|
Martin Brodie has nothing to disclose. |
|
Mauricio F. Farez, MD
(FLENI)
|
Dr. Farez has nothing to disclose. |
|
Lama Rayyis, MBBS
(King Faisal Specialist Hospital and Research Center)
|
Dr. Rayyis has nothing to disclose. |
|
Emilio Perucca
|
Emilio Perucca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sintetica. Emilio Perucca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for SKB Life Sciences. Emilio Perucca has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Xenon Pharma. Emilio Perucca has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for GRIN Therapeutics. Emilio Perucca has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sun Pharma. Emilio Perucca has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Takeda. Emilio Perucca has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Eisai. Emilio Perucca has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Xenon Pharma. Emilio Perucca has received publishing royalties from a publication relating to health care. |
|
|
No disclosure on file |
|
Mohammed Almekhlafi, MD
(King Abdulaziz University Hospital)
|
Dr. Almekhlafi has nothing to disclose. |
|
|
No disclosure on file |